Sialyltransferase 7E Inhibitors

Chemical inhibitors of Sialyltransferase 7E can interfere with its activity through various biochemical mechanisms. 3F(ax)-Neu5Ac, a sialic acid analog with a fluorine substitution, and DANA (2,3-Dehydro-2-deoxy-N-acetylneuraminic acid), another sialic acid analog, both function by resembling the natural substrate of Sialyltransferase 7E but with modifications that prevent proper enzymatic function upon binding. Similarly, CMP-Quercetin, a Cytidine Monophosphate analog, and Sia2en-PNP, compete with the natural CMP-sialic acid donor substrate for the active site, effectively inhibiting the enzyme's capability to transfer sialic acid residues. Benzyl-α-GalNAc, which is a substrate mimic for GalNAc-type glycosyltransferases, occupies the active site of Sialyltransferase 7E, disrupting its function.

ST045849 is a compound specifically designed to target sialyltransferases. It binds to the active site of Sialyltransferase 7E, directly inhibiting its function. In contrast, Lithium Chloride and PD 98,059 operate through the modulation of signaling pathways that indirectly influence Sialyltransferase 7E activity. Lithium Chloride inhibits Glycogen Synthase Kinase 3, a kinase that regulates sialyltransferases, including Sialyltransferase 7E. PD 98,059 inhibits MEK, which affects ERK signaling, subsequently altering the glycosylation patterns regulated by glycosyltransferases. Additionally, PUGNAc, an O-GlcNAcase inhibitor, increases global O-GlcNAcylation levels, which has been associated with reduced sialylation by sialyltransferases. BAY 11-7085 targets NF-κB signaling, leading to a decrease in the expression of several glycosyltransferases and thus the indirect inhibition of Sialyltransferase 7E.